Maan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 22-06-2024
- Paid Up Capital ₹ 7.14 Cr
as on 22-06-2024
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.40 Cr
as on 22-06-2024
- Satisfied Charges ₹ 46.21 Cr
as on 22-06-2024
About Maan Pharmaceuticals
The Corporate was formerly known as Maan Pharmaceuticals P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.14 Cr.
The company currently has active open charges totaling ₹37.40 Cr. The company has closed loans amounting to ₹46.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lalbhai Desai, Hemendra Patel, and Nilesh Ranka serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PLC010699
- Company No.
010699
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 May 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Maan Pharmaceuticals Ltd offer?
Maan Pharmaceuticals Ltd offers a wide range of products and services, including Mineral Supplement, Ferrous Ascorbate Tablet, Health Care Service, Trade Consultation Service, Export Consultants, Medical Consultants & Clinics, Medical Consultancy Services, Pharmaceutical Consultants, Marketing Services & Consultants, Sales Support Services.
Who are the key members and board of directors at Maan Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalbhai Desai  | Director | 13-May-1988 | Current |
| Hemendra Patel | Director | 01-Apr-2011 | Current |
| Nilesh Ranka | Director | 10-Jul-2013 | Current |
Financial Performance of Maan Pharmaceuticals.
Maan Pharmaceuticals Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maan Pharmaceuticals?
In 2023, Maan Pharmaceuticals had a promoter holding of 69.22% and a public holding of 30.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Veritas Bioventions Private LimitedActive 15 years 5 monthsHemendra Patel and Nilesh Ranka are mutual person
Nivo Lifesciences Private LimitedActive 1 year 3 monthsHemendra Patel and Nilesh Ranka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Aug 2020 | ₹2.40 Cr | Open |
Others Creation Date: 10 Mar 2016 | ₹3.00 Cr | Open |
The Mehsana Urban Co-Operative Bank Limited Creation Date: 26 Mar 2013 | ₹4.00 Cr | Open |
How Many Employees Work at Maan Pharmaceuticals?
Maan Pharmaceuticals has a workforce of 29 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
